Published in Front Cell Infect Microbiol on February 03, 2015
Induction of Shiga toxin prophage by abiotic environmental stress in food. Appl Environ Microbiol (2017) 0.75
Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med (1983) 25.72
Segregation of New Lysogenic Types during Growth of a Doubly Lysogenic Strain Derived from Escherichia Coli K12. Genetics (1954) 18.73
The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis (1985) 16.43
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet (2005) 9.78
Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis (2001) 5.27
Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis (2000) 4.24
Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med (1986) 3.61
Shiga toxin-producing Escherichia coli: an overview. J Anim Sci (2006) 3.56
Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun (1993) 3.36
Functional and genetic analysis of regulatory regions of coliphage H-19B: location of shiga-like toxin and lysis genes suggest a role for phage functions in toxin release. Mol Microbiol (1998) 2.78
Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerg Infect Dis (2000) 2.51
Two distinct toxins active on Vero cells from Escherichia coli O157. Lancet (1985) 2.47
Escherichia coli cytotoxin, haemolytic-uraemic syndrome, and haemorrhagic colitis. Lancet (1983) 2.44
Aeons of distress: an evolutionary perspective on the bacterial SOS response. FEMS Microbiol Rev (2007) 2.40
Transduction of enteric Escherichia coli isolates with a derivative of Shiga toxin 2-encoding bacteriophage phi3538 isolated from Escherichia coli O157:H7. Appl Environ Microbiol (1999) 2.37
In vivo transduction with shiga toxin 1-encoding phage. Infect Immun (1998) 2.16
Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli. Mol Microbiol (2002) 2.13
Determination of cell fate selection during phage lambda infection. Proc Natl Acad Sci U S A (2008) 2.05
Structural analysis of phage-borne stx genes and their flanking sequences in shiga toxin-producing Escherichia coli and Shigella dysenteriae type 1 strains. Infect Immun (2000) 2.01
Going viral: next-generation sequencing applied to phage populations in the human gut. Nat Rev Microbiol (2012) 1.89
Phage regulatory circuits and virulence gene expression. Curr Opin Microbiol (2005) 1.84
Shiga toxin-encoding bacteriophages--genomes in motion. Int J Med Microbiol (2004) 1.79
Cytotoxic effect of Shiga toxin-1 on human glomerular epithelial cells. Kidney Int (2000) 1.77
Analysis of the enterohemorrhagic Escherichia coli O157 DNA region containing lambdoid phage gene p and Shiga-like toxin structural genes. Appl Environ Microbiol (1996) 1.69
Outbreak of Shiga toxin-producing Escherichia coli (STEC) O104:H4 infection in Germany causes a paradigm shift with regard to human pathogenicity of STEC strains. J Food Prot (2012) 1.67
Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives. EMBO J (2000) 1.60
Abundance in sewage of bacteriophages that infect Escherichia coli O157:H7 and that carry the Shiga toxin 2 gene. Appl Environ Microbiol (1998) 1.59
Isogenic lysogens of diverse shiga toxin 2-encoding bacteriophages produce markedly different amounts of shiga toxin. Infect Immun (1999) 1.53
Diversity of stx2 converting bacteriophages induced from Shiga-toxin-producing Escherichia coli strains isolated from cattle. Microbiology (2004) 1.53
Characterizing spontaneous induction of Stx encoding phages using a selectable reporter system. Mol Microbiol (2004) 1.48
Shiga toxin 2-converting bacteriophages associated with clonal variability in Escherichia coli O157:H7 strains of human origin isolated from a single outbreak. Infect Immun (2003) 1.47
Human neutrophils and their products induce Shiga toxin production by enterohemorrhagic Escherichia coli. Infect Immun (2001) 1.47
Stx-phages: drivers and mediators of the evolution of STEC and STEC-like pathogens. Future Microbiol (2007) 1.46
Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin. Infect Immun (2003) 1.44
Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins. J Biol Chem (2006) 1.44
Self-assembly of bacteriophage lambda cI repressor: effects of single-site mutations on the monomer-dimer equilibrium. Biochemistry (1994) 1.43
Outbreak of haemolytic uraemic syndrome in Norway caused by stx2-positive Escherichia coli O103:H25 traced to cured mutton sausages. BMC Infect Dis (2008) 1.40
Influence of RecA on in vivo virulence and Shiga toxin 2 production in Escherichia coli pathogens. Microb Pathog (1999) 1.39
Bacteriocin diversity and the frequency of multiple bacteriocin production in Escherichia coli. Microbiology (2006) 1.31
Lytic and lysogenic infection of diverse Escherichia coli and Shigella strains with a verocytotoxigenic bacteriophage. Appl Environ Microbiol (2001) 1.27
Transduction of porcine enteropathogenic Escherichia coli with a derivative of a shiga toxin 2-encoding bacteriophage in a porcine ligated ileal loop system. Appl Environ Microbiol (2003) 1.26
Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease. Toxins (Basel) (2010) 1.26
Outbreaks of non-O157 Shiga toxin-producing Escherichia coli infection: USA. Epidemiol Infect (2014) 1.23
Diversity and host range of Shiga toxin-encoding phage. Infect Immun (2004) 1.20
Use of the lambda Red recombinase system to produce recombinant prophages carrying antibiotic resistance genes. BMC Mol Biol (2006) 1.18
Differential efficiency of induction of various lambdoid prophages responsible for production of Shiga toxins in response to different induction agents. Microb Pathog (2009) 1.18
The CI repressors of Shiga toxin-converting prophages are involved in coinfection of Escherichia coli strains, which causes a down regulation in the production of Shiga toxin 2. J Bacteriol (2008) 1.13
Characterizing RecA-independent induction of Shiga toxin2-encoding phages by EDTA treatment. PLoS One (2012) 1.13
Hydrogen peroxide-mediated induction of the Shiga toxin-converting lambdoid prophage ST2-8624 in Escherichia coli O157:H7. FEMS Immunol Med Microbiol (2009) 1.09
In vivo transduction of an Stx-encoding phage in ruminants. Appl Environ Microbiol (2006) 1.07
Commensal bacteria influence Escherichia coli O157:H7 persistence and Shiga toxin production in the mouse intestine. Infect Immun (2006) 1.06
Sequence analysis of Escherichia coli O157:H7 bacteriophage PhiV10 and identification of a phage-encoded immunity protein that modifies the O157 antigen. FEMS Microbiol Lett (2009) 1.01
Shiga toxin 2 is specifically released from bacterial cells by two different mechanisms. Infect Immun (2009) 1.01
Induction of Shiga toxin-converting prophage in Escherichia coli by high hydrostatic pressure. Appl Environ Microbiol (2005) 1.01
Altruism of Shiga toxin-producing Escherichia coli: recent hypothesis versus experimental results. Front Cell Infect Microbiol (2013) 0.98
The highly virulent 2006 Norwegian EHEC O103:H25 outbreak strain is related to the 2011 German O104:H4 outbreak strain. PLoS One (2012) 0.97
Shiga toxin-converting phages and the emergence of new pathogenic Escherichia coli: a world in motion. Front Cell Infect Microbiol (2014) 0.94
Receptor affinity, stability and binding mode of Shiga toxins are determinants of toxicity. Microb Pathog (2007) 0.91
Globotriaosylceramide (Gb3) content in HeLa cells is correlated to Shiga toxin-induced cytotoxicity and Gb3 synthase expression. BMB Rep (2009) 0.90
Shiga toxin pathogenesis: kidney complications and renal failure. Curr Top Microbiol Immunol (2012) 0.86
Following cell-fate in E. coli after infection by phage lambda. J Vis Exp (2011) 0.84